Back
NV5 Global Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
19
NVEE
NV5 Global
Last Price:
23.30
Seasonality Move:
5.53%
Buy
70
MDGL
Madrigal Pharmaceuticals
Last Price:
331.02
Seasonality Move:
31.67%
Sell
19
NV5 Global (NVEE)
is a Sell
Is NV5 Global a Buy, Sell or Hold?
- The current NV5 Global [NVEE] share price is $23.29. The Score for NVEE is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- NVEE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
70
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $331.32. The Score for MDGL is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVEE Stock Price Chart
What is NV5 Global's stock price today?
-
The NV5 Global share price today is $23.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVEE is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $331.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVEE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 53.45 | Buy |
| Chaikin Money Flow: | 71146 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.53 - 23.45) | Buy |
| Bollinger Bands (100): | (22.55 - 24.39) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.42 | Buy |
| Relative Strength Index (14 RSI): | 86.69 | Buy |
| Chaikin Money Flow: | 576514 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (190.5 - 254.66) | Buy |
| Bollinger Bands (100): | (221.16 - 280.26) | Buy |
NVEE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.74 | Buy |
| 20-day SMA: | 22.99 | Buy |
| 50-day SMA: | 23.03 | Buy |
| 200-day SMA: | 24.06 | Sell |
| 8-day EMA: | 22.97 | Buy |
| 20-day EMA: | 22.96 | Buy |
| 50-day EMA: | 23.12 | Buy |
| 200-day EMA: | 23.98 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 246.83 | Buy |
| 20-day SMA: | 225.95 | Buy |
| 50-day SMA: | 229.96 | Buy |
| 200-day SMA: | 241.65 | Buy |
| 8-day EMA: | 263.88 | Buy |
| 20-day EMA: | 237.89 | Buy |
| 50-day EMA: | 234.01 | Buy |
| 200-day EMA: | 235.45 | Buy |
NV5 Global Earnings Growth & NVEE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.11 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.19 per share, and an increase next year of $9.06 per share.
NV5 Global Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||